Immunic, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Immunic, Inc. (IMUX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $0 as of 2019-03-31, per its 10-Q filed 2019-04-10.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2019-04-10
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2018-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $10.96M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-04-10 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-04 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $10.96M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $9.64M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $6.71M 10-K · filed 2018-03-13 |
| 2017-09-30 | $4.56M 10-Q · filed 2017-10-25 |
| 2017-06-30 | $979.13K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.41M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $1.56M 10-K · filed 2017-03-07 |
| 2016-09-30 | $3.29M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $3.38M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $9.00M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $17.28M 10-K · filed 2016-03-08 |
| 2015-09-30 | $1.55M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $42.94M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $55.45M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $55.84K 10-K · filed 2015-03-20 |
| 2014-09-30 | $43.80M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $65.48M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $15.03M 10-Q · filed 2014-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |